Depression in patients with heart disease: the case for more trials

Stanley S Liu1, Roy C Ziegelstein

  • 1Johns Hopkins Bayview Medical Center, Department of Medicine, B-1-North, 4940 Eastern Avenue, Baltimore, MD 21224-2780, USA.

Future Cardiology
|July 9, 2010
PubMed

Insights

Depression is a common comorbidity in heart disease patients, impacting quality of life and health behaviors. Further trials are needed to confirm if treating depression improves cardiac outcomes and survival rates.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Trials

Background:

  • Depression is a prevalent comorbidity in patients with heart disease.
  • It negatively affects quality of life and adherence to healthy behaviors.
  • Depression is linked to increased morbidity and mortality in cardiovascular disease.

Purpose of the Study:

  • To advocate for more clinical trials investigating the impact of depression treatment on cardiac outcomes.
  • To emphasize the need for evidence-based treatment strategies for depression in cardiovascular patients.
  • To explore the potential influence of improved survival rates on clinical practice.

Main Methods:

  • Review of existing literature on depression in heart disease.
  • Analysis of prior trial results to inform future research hypotheses.
  • Discussion of the implications of potential findings for clinical practice.

Main Results:

  • No study has definitively shown that treating depression improves cardiac outcomes in heart disease patients.
  • Existing evidence suggests a strong association between depression and adverse cardiac events.
  • The potential benefits of depression treatment on survival remain unproven but are clinically significant.

Conclusions:

  • Despite the lack of definitive proof, the high prevalence and impact of depression warrant further investigation.
  • Future trials should leverage existing data to design studies that can demonstrate improved cardiac outcomes and survival.
  • Establishing a causal link between depression treatment and improved cardiac health could significantly alter clinical management.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...